Bajaj Healthcare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
419.50
-4.7 (-1.11%)
BSENSE

Dec 05

BSE+NSE Vol: 28.8 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Bajaj Healthcare Ltd stock-summary
stock-summary
Bajaj Healthcare Ltd
Small Cap
Pharmaceuticals & Biotechnology
Bajaj Healthcare Ltd. is a bulk drug manufacturer established in 1993, serving various Pharmaceuticals, Nutraceuticals and Food industries globally with a spirit of scrupulousness. The Company commenced its operations in 1993 with a single unit at Tarapur. It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra.
Company Coordinates stock-summary
Company Details
602-606 Bhoomi Velocity Infote, Road No 23 Wagle Indl Estate Thane Maharashtra : 400604
stock-summary
Tel: 91-22-66177400/401
stock-summary
investors@bajajhealth.com
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 13.80 Cr
Number of Shares
2.76 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
28-Sep-2021
2.76
13.80
13799200
5
Stock Split
09-Apr-2019
1.38
13.80
6899600
10
Bonus
09-Apr-2019
1.38
13.80
6899600
5
Bonus Issue
10-May-2016
69
6.90
149600
10
Public Issues
10-May-2016
69
6.90
149600
10
Public Issues
06-May-2016
69
6.90
149600
5
Public Issue
18-Jan-2016
67.5
6.75
4500000
10
Bonus
18-Jan-2016
67.5
6.75
4500000
5
Bonus Allotment
01-Oct-2009
22.5
2.25
250000
10
Allotment of Equity To Others
31-Jan-2009
2
2.00
1900000
10
Bonus
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 3 Schemes (1.66%)

FIIs

Held by 10 FIIs (1.12%)

Promoter with highest holding

Sajankumar Rameshwarlal Bajaj (37.59%)

Highest Public shareholder

Vanaja Sundar Iyer (2.2%)

Individual Investors Holdings

26.24%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Sanjankumar R Bajaj
Chairman & Managing Director
48.0 lacs
Anil C Jain
Joint Managing Director
46.0 lacs
Namrata S Bajaj
Whole-time Director
10.15 lacs
Dhananjay S Halte
Whole-time Director
13.59 lacs
Rupesh H Nikam
Whole Time Director & CFO
16.15 lacs
Ram B Banarase
Independent Director
60.0 k
Hemant R Karnik
Independent Director
1.2 lacs
Aakashkumar Kesari
Company Secretary
7.49 lacs
Avinash Dalal
Independent Director
35.0 k
Loukik D Tipnis
Independent Director
45.0 k
Luke Benedict Fernandez
Independent Director
0
Kejal Shah
Independent Director
0
Pakshal Jain
Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Material Consumed
268.32053
0%
 
100
Raw Material Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Processing Charges
2.44
0.75%
 
0.75
Processing Charges
99.25
Processing Charges
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
148 Cr
(Quarterly Results - Sep 2025)
Net Profit:
11 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 1,326 Cr (Small Cap)

stock-summary
P/E

26.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.24%

stock-summary
Debt Equity

0.46

stock-summary
Return on Equity

10.45%

stock-summary
Price to Book

2.76